Logo image of MAX

MEDIAALPHA INC-CLASS A (MAX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:MAX - US58450V1044 - Common Stock

11.49 USD
-0.05 (-0.43%)
Last: 1/13/2026, 12:05:39 PM
Fundamental Rating

5

Overall MAX gets a fundamental rating of 5 out of 10. We evaluated MAX against 70 industry peers in the Interactive Media & Services industry. While MAX seems to be doing ok healthwise, there are quite some concerns on its profitability. MAX is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MAX had positive earnings in the past year.
In the past year MAX had a positive cash flow from operations.
MAX had negative earnings in 4 of the past 5 years.
MAX had a positive operating cash flow in each of the past 5 years.
MAX Yearly Net Income VS EBIT VS OCF VS FCFMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

MAX's Return On Assets of -0.43% is in line compared to the rest of the industry. MAX outperforms 52.86% of its industry peers.
Looking at the Return On Invested Capital, with a value of 74.11%, MAX belongs to the top of the industry, outperforming 98.57% of the companies in the same industry.
Industry RankSector Rank
ROA -0.43%
ROE N/A
ROIC 74.11%
ROA(3y)-17.95%
ROA(5y)-11.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MAX Yearly ROA, ROE, ROICMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 400 600

1.3 Margins

MAX's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 6.39%, MAX is in the better half of the industry, outperforming 61.43% of the companies in the same industry.
In the last couple of years the Operating Margin of MAX has declined.
MAX's Gross Margin of 15.29% is on the low side compared to the rest of the industry. MAX is outperformed by 85.71% of its industry peers.
In the last couple of years the Gross Margin of MAX has declined.
Industry RankSector Rank
OM 6.39%
PM (TTM) N/A
GM 15.29%
OM growth 3Y147.63%
OM growth 5Y-25.49%
PM growth 3YN/A
PM growth 5Y-15.11%
GM growth 3Y1.82%
GM growth 5Y-10.7%
MAX Yearly Profit, Operating, Gross MarginsMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MAX is creating value.
Compared to 1 year ago, MAX has more shares outstanding
The number of shares outstanding for MAX has been increased compared to 5 years ago.
MAX has a better debt/assets ratio than last year.
MAX Yearly Shares OutstandingMAX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MAX Yearly Total Debt VS Total AssetsMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

MAX has an Altman-Z score of 4.01. This indicates that MAX is financially healthy and has little risk of bankruptcy at the moment.
MAX has a better Altman-Z score (4.01) than 75.71% of its industry peers.
The Debt to FCF ratio of MAX is 1.78, which is an excellent value as it means it would take MAX, only 1.78 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MAX (1.78) is better than 77.14% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.78
Altman-Z 4.01
ROIC/WACC8.82
WACC8.4%
MAX Yearly LT Debt VS Equity VS FCFMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

MAX has a Current Ratio of 1.08. This is a normal value and indicates that MAX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.08, MAX is doing worse than 71.43% of the companies in the same industry.
MAX has a Quick Ratio of 1.08. This is a normal value and indicates that MAX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.08, MAX is doing worse than 71.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 1.08
MAX Yearly Current Assets VS Current LiabilitesMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.41% over the past year.
MAX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.88% yearly.
Looking at the last year, MAX shows a very strong growth in Revenue. The Revenue has grown by 64.86%.
The Revenue has been growing by 16.21% on average over the past years. This is quite good.
EPS 1Y (TTM)29.41%
EPS 3YN/A
EPS 5Y0.88%
EPS Q2Q%52.94%
Revenue 1Y (TTM)64.86%
Revenue growth 3Y10.25%
Revenue growth 5Y16.21%
Sales Q2Q%18.28%

3.2 Future

Based on estimates for the next years, MAX will show a very strong growth in Earnings Per Share. The EPS will grow by 46.44% on average per year.
The Revenue is expected to grow by 11.57% on average over the next years. This is quite good.
EPS Next Y-57.45%
EPS Next 2Y88.4%
EPS Next 3Y62.55%
EPS Next 5Y46.44%
Revenue Next Year30.97%
Revenue Next 2Y19.2%
Revenue Next 3Y16.23%
Revenue Next 5Y11.57%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MAX Yearly Revenue VS EstimatesMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B
MAX Yearly EPS VS EstimatesMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 -1 2

5

4. Valuation

4.1 Price/Earnings Ratio

MAX is valuated quite expensively with a Price/Earnings ratio of 52.23.
MAX's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of MAX to the average of the S&P500 Index (27.25), we can say MAX is valued expensively.
With a Price/Forward Earnings ratio of 10.79, the valuation of MAX can be described as very reasonable.
80.00% of the companies in the same industry are more expensive than MAX, based on the Price/Forward Earnings ratio.
MAX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.98.
Industry RankSector Rank
PE 52.23
Fwd PE 10.79
MAX Price Earnings VS Forward Price EarningsMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

70.00% of the companies in the same industry are more expensive than MAX, based on the Enterprise Value to EBITDA ratio.
MAX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MAX is cheaper than 84.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.58
EV/EBITDA 11.41
MAX Per share dataMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

MAX's earnings are expected to grow with 62.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)59.07
EPS Next 2Y88.4%
EPS Next 3Y62.55%

0

5. Dividend

5.1 Amount

MAX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

MEDIAALPHA INC-CLASS A

NYSE:MAX (1/13/2026, 12:05:39 PM)

11.49

-0.05 (-0.43%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-23 2026-02-23/amc
Inst Owners53.97%
Inst Owner Change0%
Ins Owners9.16%
Ins Owner Change-1.4%
Market Cap748.80M
Revenue(TTM)1.12B
Net Income(TTM)-1.14M
Analysts78.33
Price Target16.25 (41.43%)
Short Float %4.71%
Short Ratio3.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-129.76%
Min EPS beat(2)-293.83%
Max EPS beat(2)34.31%
EPS beat(4)2
Avg EPS beat(4)-70.69%
Min EPS beat(4)-293.83%
Max EPS beat(4)40.96%
EPS beat(8)6
Avg EPS beat(8)108.86%
EPS beat(12)6
Avg EPS beat(12)45.95%
EPS beat(16)7
Avg EPS beat(16)23.79%
Revenue beat(2)1
Avg Revenue beat(2)3.11%
Min Revenue beat(2)-0.61%
Max Revenue beat(2)6.83%
Revenue beat(4)3
Avg Revenue beat(4)4.76%
Min Revenue beat(4)-0.61%
Max Revenue beat(4)10.52%
Revenue beat(8)7
Avg Revenue beat(8)7.27%
Revenue beat(12)10
Avg Revenue beat(12)6.27%
Revenue beat(16)12
Avg Revenue beat(16)5.03%
PT rev (1m)0%
PT rev (3m)-0.96%
EPS NQ rev (1m)-3.25%
EPS NQ rev (3m)10.19%
EPS NY rev (1m)-6.6%
EPS NY rev (3m)20.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.26%
Valuation
Industry RankSector Rank
PE 52.23
Fwd PE 10.79
P/S 0.67
P/FCF 8.58
P/OCF 8.55
P/B N/A
P/tB N/A
EV/EBITDA 11.41
EPS(TTM)0.22
EY1.91%
EPS(NY)1.06
Fwd EY9.27%
FCF(TTM)1.34
FCFY11.65%
OCF(TTM)1.34
OCFY11.7%
SpS17.23
BVpS-0.46
TBVpS-1.25
PEG (NY)N/A
PEG (5Y)59.07
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.43%
ROE N/A
ROCE 93.81%
ROIC 74.11%
ROICexc 150.46%
ROICexgc N/A
OM 6.39%
PM (TTM) N/A
GM 15.29%
FCFM 7.77%
ROA(3y)-17.95%
ROA(5y)-11.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y414.71%
ROICexgc growth 5Y-22.99%
ROICexc growth 3Y231.94%
ROICexc growth 5Y-23.15%
OM growth 3Y147.63%
OM growth 5Y-25.49%
PM growth 3YN/A
PM growth 5Y-15.11%
GM growth 3Y1.82%
GM growth 5Y-10.7%
F-Score5
Asset Turnover4.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.78
Debt/EBITDA 1.76
Cap/Depr 8.01%
Cap/Sales 0.03%
Interest Coverage 5.79
Cash Conversion 115.01%
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 1.08
Altman-Z 4.01
F-Score5
WACC8.4%
ROIC/WACC8.82
Cap/Depr(3y)4.14%
Cap/Depr(5y)8.08%
Cap/Sales(3y)0.04%
Cap/Sales(5y)0.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.41%
EPS 3YN/A
EPS 5Y0.88%
EPS Q2Q%52.94%
EPS Next Y-57.45%
EPS Next 2Y88.4%
EPS Next 3Y62.55%
EPS Next 5Y46.44%
Revenue 1Y (TTM)64.86%
Revenue growth 3Y10.25%
Revenue growth 5Y16.21%
Sales Q2Q%18.28%
Revenue Next Year30.97%
Revenue Next 2Y19.2%
Revenue Next 3Y16.23%
Revenue Next 5Y11.57%
EBIT growth 1Y158.25%
EBIT growth 3Y173%
EBIT growth 5Y-13.41%
EBIT Next Year145.71%
EBIT Next 3Y44.78%
EBIT Next 5Y29.51%
FCF growth 1Y965.06%
FCF growth 3Y17.37%
FCF growth 5Y15.66%
OCF growth 1Y960.23%
OCF growth 3Y17.03%
OCF growth 5Y15.68%

MEDIAALPHA INC-CLASS A / MAX FAQ

Can you provide the ChartMill fundamental rating for MEDIAALPHA INC-CLASS A?

ChartMill assigns a fundamental rating of 5 / 10 to MAX.


What is the valuation status of MEDIAALPHA INC-CLASS A (MAX) stock?

ChartMill assigns a valuation rating of 5 / 10 to MEDIAALPHA INC-CLASS A (MAX). This can be considered as Fairly Valued.


How profitable is MEDIAALPHA INC-CLASS A (MAX) stock?

MEDIAALPHA INC-CLASS A (MAX) has a profitability rating of 3 / 10.


What is the valuation of MEDIAALPHA INC-CLASS A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MEDIAALPHA INC-CLASS A (MAX) is 52.23 and the Price/Book (PB) ratio is -25.17.


Can you provide the financial health for MAX stock?

The financial health rating of MEDIAALPHA INC-CLASS A (MAX) is 5 / 10.